Search
Search Funnelback University
- Refined by:
- Date: 2021
Your query has been expanded to news |u:www.enterprize.cam.ac.uk. Search for news |u:www.enterprise.cam.ac.uk instead.
51 -
71 of
71
search results for news |u:www.enterprise.cam.ac.uk or news |u:www.enterprize.cam.ac.uk
Fully-matching results
-
Q-Flo: progress towards a materials revolution – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/making-progress-towards-a-materials-revolution-2/5 May 2021: This collaboration has put our business in a very strong position and with continued support from Dr Boies and his group we look forward to developing and exploiting this exciting new -
Quantum computing Riverlane secures $20m – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-quantum-computing-software-spin-out-secures-20m-in-series-a-funding/18 Mar 2021: Share:. The new funding will accelerate Riverlane’s mission to build a high-performance operating system that makes quantum computers useful, sooner. ... This new funding follows a £3.25 million seed round completed in June 2019. -
Student innovation and entrepreneurship training in China – Cambridge …
https://www.enterprise.cam.ac.uk/case-studies/student-innovation-and-entrepreneurship-training-in-china/16 Jun 2021: Topics included how to identify a good idea, assess its viability, develop a value proposition and business model, and financing a new venture. -
Annual Review2020 /Where ideas thrive 2 Cambridge Enterprise Annual…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/01/Cambridge-Enterprise-Annual-Review-2020.pdf12 Mar 2021: Many also want to learn about new and ground-breaking technologies and companies originating from the University of Cambridge. ... Launched in 2018, Bad News has now been played over a million times. -
ApcinteX share SerpinPC clinical trial results – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-apcintex-shares-results-from-study-of-serpinpc/18 Mar 2021: ApcinteX's single ascending dose study assesses SerpinPC, its investigational drug for the treatment of haemophilia. -
Novel therapeutic for neuropathic pain – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/new-approach-could-revolutionise-treatment-of-neuropathic-pain/2 Aug 2021: University of Cambridge-based research has led to the development of a new approach to the treatment of neuropathic pain, caused by nerve damage. -
Cambridge Enterprise-led Ceres Agri-Tech launches first three…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-led-ceres-agri-tech-launches-first-three-spin-outs/21 Dec 2021: Share:. Mushroom-harvesting robot is among innovations from new agri-tech partnership. The first three spin-out companies have been launched from a government-backed knowledge exchange partnership designed to revolutionise ... Robotic mushroom picking, -
PolyProx Therapeutics receives £1m from LifeArc – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-polyprox-therapeutics-raises-an-additional-1m-seed-financing/25 Feb 2021: capital from new investor, LifeArc. ... We are delighted to welcome LifeArc as an investor which enables us to expand our drug discovery resources following our recent move to new laboratories in Cambridge. -
Xampla pioneers sustainable alternative to plastic – Cambridge…
https://www.enterprise.cam.ac.uk/case-studies/xampla-microengineering-a-solution-to-the-global-plastics-crisis/21 Jun 2021: In October, Xampla appointed Jeff Seabright, former Chief Sustainability Officer at Unilever and a White House climate change advisor during the Clinton administration, as its new Chair. -
PowerPoint Presentation
https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/11/Marketing-Sheet_Low-loss-high-speed-data-transmission_Mol-7671-20_18-11-2021.pdf18 Nov 2021: the University of Cambridge have developed a new data transmission design based on a pair of Goubau Lines – metallic tracks or wires with a carefully defined separation, tailored to the frequency ... By using an appropriate antenna as a “launcher” -
Apollo Therapeutics launches as multinational company, backed by…
https://www.enterprise.cam.ac.uk/news/apollo-therapeutics-launches-as-multinational-company-backed-by-100m-investment/17 Aug 2021: With proceeds from this financing, Apollo plans to advance its lead therapeutic programmes into clinical development as well as identify new programmes. ... In addition, the company plans to expand its UK operations in the Cambridge area, as well as in -
– Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/dish-life-lab-in-your-phone-lets-you-play-the-scientific-life/23 Oct 2021: This helps build experience points, unlocking new abilities such as hiring researchers and buying equipment. ... We hope the game offers new ideas and stories for imagining what a scientist looks like, and how the modern scientific life is lived.”. -
NonExomics 'dark genome' research published in Molecular…
https://www.enterprise.cam.ac.uk/news/dark-genome-research-licensed-to-start-up-nonexomics-published-in-molecular-psychiatry/22 Dec 2021: We’ve found new proteins that are involved in biological processes and are dysfunctional in disorders like schizophrenia and bipolar disorder.”. ... The new finding helps to explain why schizophrenia and bipolar disorder are heritable conditions, and -
Case study: NoBACZ Healthcare – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/nobacz-healthcare-novel-solution-for-treating-digital-dermatitis-in-cows/5 May 2021: In late 2017 Powell and Faria approached us with an idea. Although they had many previous patents to their names, this new idea was the first that they felt sufficiently passionate ... and analyse the business case for creating a new company. -
Cambridge and Shandong University sign agreement to support…
https://www.enterprise.cam.ac.uk/news/cambridge-and-shandong-university-sign-agreement-to-support-innovation-and-entrepreneurship/3 Mar 2021: The new school will be supported by Cambridge Enterprise, Shandong University and Qingdao Municipal Government. -
Astrologaster case study – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/astrologaster-a-story-driven-astrological-video-game-set-in-shakespeares-london/5 May 2021: It was a new world for me,” says Kassell. “Cambridge Enterprise explained why I needed a contract to work with Nyamyam and put everything in place without any hassle.”. ... An article in the magazine Prospect noted Kassell’s role not merely in -
Flusso raises £5.7m series A – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-flusso-raises-5-7m-series-a-to-disrupt-8bn-flow-monitoring-market/25 Feb 2021: Flusso sensor next to pencil. The round was led by existing investor Parkwalk Advisors and new investor Foresight Williams Technology EIS Fund, with participation fromand Cambridge angels. -
Granta Design and CASTEP case studies – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/granta-design-and-castep-supporting-materials-software-pioneers-for-25-years/5 May 2021: When a new company spins out of the University, a member of our staff often sits on its board, ready with advice and connections. ... We now look forward to many more years of success and the broader application of CASTEP to new industrial problems. -
Cambridge spin-out doses first subject with treatment for…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-doses-first-subject-with-treatment-for-alpha-1-antitrypsin-deficiency/25 Feb 2021: Drug development company Z Factor Ltd announced that the first human volunteer was dosed today with ZF874, its novel treatment for AATD. -
Cambridge Enterprise licenses PREDICT algorithm to ONCOassist –…
https://www.enterprise.cam.ac.uk/news/oncoassist-app-adds-predict-algorithm-licensed-from-cambridge-enterprise-to-help-doctors-make-critical-treatment-decisions-following-breast-cancer-surgery/21 Oct 2021: The addition of the PREDICT breast algorithm will enhance our platform with new functionality to help clinicians make informed decisions about adjuvant treatment following breast cancer surgery. ... ONCOassist Chief Medical Officer Dr Richard Bambury said -
Rapid COVID-19 diagnostic test developed – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/rapid-covid-19-diagnostic-test-developed-by-cambridge-spin-out-to-be-deployed-in-hospitals/25 Feb 2021: Share:. A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spin-out company and capable of diagnosing the infection in under 90 minutes, is being deployed
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.